Role of growth factors in pancreatic cancer

Surgical Oncology Clinics of North America

Volumn 7, Issue 1, 1998, Pages 25-41

  Korc, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; BETACELLULIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIREGULIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; INSULIN; INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER INHIBITION; HUMAN; ONCOGENE K RAS; PANCREAS CANCER; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031934765     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30283-7     Document Type: Review

References (110)

1. Aaronson S.A. Growth factors and cancer Science 254 1991 1146 1153
2. Almoguera C. Shibata D. Forrester K. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549 554
3. Attisano L. Caracamo J. Ventura F. Identification of human activin and TGFß type I receptors that form heteromeric complexes with type II receptors Cell 75 1993 671 680
4. Attisano L. Wrana J.L. Cheifetz S. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors Cell 68 1992 97 108
5. Baldwin R.L. Friess H. Yokoyama M. Attenuated ALK5 receptor expression in human pancreatic cancer: Correlation with resistance to growth inhibition Int J Cancer 67 1996 283 288
6. Barton C.M. Staddon S.L. Hughes C.M. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer Br J Cancer 64 1991 1076 1082
7. Bergmann U. Funatomi H. Kornmann M. Increased expression of insulin receptor substrate-1 in human pancreatic cancer Biochem Biophys Res Commun 220 1996 886 890
8. Bergmann U. Funatomi H. Kornmann M. Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1: In vivo evidence for an isletcancer cell axis International Journal of Oncology 9 1996 487 492
9. Bergmann U. Funatomi H. Yokoyama M. Insulin-like growth factor I overexpression in human pancreatic cancer: Evidence for autocrine and paracrine roles Cancer Res 55 1995 2007 2011
10. Boyer J.C. Umar A. Risinger J.I. Microsatellite instability, mismatch repair deficiency, and genetic defects in human cancer cell lines Cancer Res 1995 55 1995 6063 6070
11. Carraway K.L. Cantley L.C. A Neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling Cell 78 1994 5 8
12. Casey G. Yamanaka Y. Friess H. p53 Mutations are common in pancreatic cancer and are absent in chronic pancreatitis Cancer Lett 69 1993 151 160
13. Cheatham B. Kahn C.R. Insulin action and the insulin signaling network Endocr Rev 16 1995 117 142
14. Daughaday W.H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors [editorial] Endocrinology 127 1990 14
15. Derynck R. Zhang Y. The mad way to do it Current Biology 6 1996 1226 1229
16. Di Renzo M.F. Poulsom R. Olivero M. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer Cancer Res 55 1995 1129 1138
17. Ebert M. Yokoyama M. Friess H. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer Int J Cancer 62 1995 529 535
18. Ebert M. Yokoyama M. Friess H. Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer Cancer Res 54 1994 5775 5778
19. Ebert M. Yokoyama M. Kobrin M.S. Induction and expression of amphiregulin in human pancreatic cancer Cancer Res 54 1994 3959 3962
20. Ebner R. Chen R.H. Shum L. Cloning of a type I TGF-ß receptor and its effect on binding to the type II receptor Science 260 1993 1344 1348
21. Ebner R. Chen R.H. Lawler S. Determination of type I receptor specificity by the type II receptors for TGF-ß and activin Science 262 1993 900 902
22. Estival A. Monzat V. Miguel K. Differential regulation of mRNA and protein by two molecular forms of basic FGF: Modulation of FGRF-1 mRNA stability J Biol Chem 271 1996 5663 5670
23. Fava R.A. Olsen N.J. Postlethwaite A.E. Transforming growth factor ßl (TGF-ßl) induced neutrophil recruitment to synovial tissues: Implications for the TGF- ß -driven synovial inflammation and hyperplasia J Exp Med 173 1993 1121 1129
24. Fen Z. Dhadly M.S. Yoshizumi M. Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factorlike growth factor/diphteria toxin receptor Biochemistry 32 1993 7932 7938
25. Franzen P. ten Dijke P. Ichijo H. Cloning of a TGF-ß type I receptor that forms a heteromeric complex with the TGF-ß type II receptor Cell 75 1993 681 692
26. Freeman J. Ahmed M. Kolaparthi V. A novel mutation of the TGF-ß receptor type II gene contributes to the tumorigenic properties of the human pancreatic cancer cell line MIA PaCA-2 AACR Proceedings 38 1997 65A
27. Friess H. Yamanaka Y. Büchler M. Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis Int J Cancer 56 1994 668 674
28. Friess H. Yamanaka Y. Büchler M. Enhanced expression of transforming growth factor-beta isoforms in human pancreatic cancer correlates with decreased survival Gastroenterology 105 1993 1846 1856
29. Friess H. Yamanaka Y. Büchler M. Enhanced expression of the type II transforming growth factor ßreceptor in human pancreatic cancer cells without alteration of type III receptor expression Cancer Res 53 1993 2704 2707
30. Friess H. Yamanaka Y. Kobrin M.S. Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression Clinical Cancer Research 1 1995 1413 1420
31. Funatomi H. Itakura J. Ishiwata T. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor targeted therapy Int J Cancer 72 1997 512 517
32. Georgi L.L. Albert P.S. Riddle D.L. daf- 1, a C. elegans gene controlling dauer larva development, encodes a novel receptor protein kinase Cell 61 1990 635 645
33. Givol D. Yayon A. Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity FASEB J 6 1992 336 339
34. Goldstein A.M. Fraser M.C. Struewing J.P. Increased risk of pancreatic cancer in melanoma-prone kindreds with pl6INK4 mutations N Engl J Med 333 1995 970 974
35. Gomella L.G. Sargent E.R. Wade T.P. Expression of transforming growth factor a in normal human adult kidney and enhanced expression of transforming growth factors α and - ß1 in renal cell carcinoma Cancer Res 49 1989 6972 6975
36. Gorsch S.M. Memoli V.A. Stukel T.A. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer Cancer Res 52 1992 6949 6952
37. Grunewald K. Lyons J. Frohlich A. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas Int J Cancer 43 1989 1037 1041
38. Gudjonsson B. Cancer of the pancreas: 50 years of surgery Cancer 60 1987 2284 2303
39. Hahn S.A. Schutte M. Shansul Hoque A.T.M. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 268 1996 350 353
40. Hasegqawa Y. Takada M. Yamamot M. The gradient of basic fibroblast growth factor concentration in human pancreatic cancer cell invasion Biochem Biophys Res Commun 200 1994 1435 1439
41. Heino J. Ignotz R.A. Hemler M.E. Regulation of cell adhesion receptors by transforming growth factor β J Biol Chem 264 1989 380 390
42. Henderson J.R. Daniel P.M. A comparative study of the portal vessels connecting the endocrine and exocrine pancreas, with a discussion of some functional implications Quarterly Journal of Experimental Physiology and Cognitive Medical Sciences 64 1979 267 275
43. Hynes R.O. Integrins: Versatility, modulation, and signaling in cell adhesion Cell 69 1992 11 19
44. Ishiwata T, Bergmann U, Kornmann M, et al: Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. Pancreas, in press
45. Ishiwata T. Friess H. Büchler M.W. KGF and its receptor are co-expressed in human pancreatic cancer Pancreas 13 1996 440A
46. Ito N. Kawata S. Tamura S. Elevated levels of transforming growth factor 1 messenger RNA and its polypeptide in human hepatocellular carcinoma Cancer Res 51 1991 4080 4083
47. Jaye M. Schlessinger J. Dionne C. Fibroblast growth factor receptor tyrosine kinases: Molecular analysis and signal transduction Biochim Biophys Acta 1135 1992 185 199
48. Jennings M.T. Maciunas R.J. Carver R. TGF-βl and TGF-β2 are potent growth regulators for low-grade and malignant gliomas in vitro: Evidence in support of an autocrine hypothesis Int J Cancer 49 1991 129 139
49. Johnson D.E. Williams L.T. Structural and functional diversity in the FGF receptor multigene family Adv Cancer Res 60 1993 1 18
50. Johnson G.R. Saeki T. Gordon A.W. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon J Cell Biol 118 1992 741 751
51. Kadin M.E. Cavaille-Coll M.W. Gertz R. Loss of receptors for transforming growth factor β in human T cell malignancies Proc Natl Acad Sci U S A 91 1994 6002 6006
52. Kim I.Y. Ahn H.J. Zelner D.J. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells Cancer Res 56 1996 44 48
53. Kingsley D.M. The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms Genes Dev 8 1994 133 146
54. Kobrin M.S. Funatomi H. Friess H. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer Biochem Biophys Res Commun 202 1994 1705 1709
55. Kobrin M.S. Yamanaka Y. Friess H. Aberrant expression of the type I fibroblast growth factor receptor in human pancreatic adenocarcinomas Cancer Res 53 1993 4741 4744
56. Korc M. Normal function of the endocrine pancreas Go V.L.W. DiMagno E.P. Gardner J.D. The Pancreas: Biology, Pathobiology and Disease 1993 Raven Press New York 751 758
57. Korc M. Chandrasekar B. Yamanaka Y. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha J Clin Invest 90 1992 1352 1360
58. Kornmann M. Ishiwata T. Beger H.G. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: Evidence for autocrine and paracrine actions Oncogene 15 1997 1417 1424
59. Lemoine N.R. Lobresco M. Leung H. The erbB-3 gene in human pancreatic cancer J Pathol 168 1992 269 273
60. Le Roith D. Insulin-like growth factors N Engl J Med 336 1997 633 640
61. Leung H.Y. Gullick W.J. Lemoine N.R. Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer Int J Cancer 59 1994 667 675
62. Lin H.Y. Wang X.-F. Ng-Eaton E. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase Cell 68 1992 775 785
63. Macaulay V.M. Insulin-like growth factors and cancer Br J Cancer 65 1992 311 320
64. Massagué J. TGF-beta signaling: Receptors, transducers, and Mad proteins Cell 85 1996 947 950
65. Massagué J. Pandiella A. Membrane-anchored growth factors Annu Rev Biochem 62 1993 515 541
66. Marchionni M.A. Goodearl A.D.J. Chen M.S. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system Nature 362 1993 312 318
67. Markowitz S. Wang J. Meyerhoff L. Inactivation of the TGF-β type II receptor in colon cancer cells with microsatellite instability Science 268 1995 1336 1338
68. Mason I.J. The ins and outs of fibroblast growth factors Cell 78 1994 547 552
69. Meyerhoff L.L. Parsons R. Kim A-J A transforming growth factor-β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability Cancer Res 55 1995 5545 5547
70. Miki T. Bottaro D.P. Fleming T.P. Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene Proc Natl Acad Sci USA 89 1992 246 250
71. Minniti C.P. Kohn E.C. Grubb J.H. The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells J Biol Chem 267 1992 9000 9004
72. Nakamura T. Sugino K. Kurosawa N. Isolation and characterization of activin receptor from mouse embryonal carcinoma cells J Biol Chem 267 1992 18924 18928
73. Nissley P. Kiess W. Sklar M.M. The insulin-like growth factor II/mannose 6-phosphate receptor Le Roith D. Insulin-like Growth Factors: Molecular and Cellular Aspects 1991 CRC Press Boca Raton, FL 111 150
74. Ohta M. Greenberger J.S. Anklesaria P. Two forms of transforming growth factor-β distinguished by multipotential haematopoetic progenitor cells Nature 329 1987 539 543
75. Ornitz D.M. Xu J. Colvin J.S. Receptor specificity of the fibroblast growth factor family J Biol Chem 271 1996 15292 15297
76. Parekh T. Saxena B. Reibman J. Neutrophil chemotaxis in response to TGF-β isoforms (TGF-βl, TGF-β2, TGF-β3) is mediated by fibronectin J Immunol 152 1994 2456 2461
77. Park K. Kim S-J Bang Y-J Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-β Proc Natl Acad Sci U S A 91 1994 8772 8776
78. Pawson T. Schlessinger J. SH2 and SH3 domains Current Biology 3 1993 434 442
79. Peles E. Bacus S.S. Koski R.A. Isolation of the Neu/HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells Cell 69 1992 205 216
80. Plowman G.D. Green J.M. McDonald V.L. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity Mol Cell Biol 10 1990 1969 1981
81. Prigent S.A. Lemoine N.R. The type 1 (EGFR-related) family of growth factor receptors and their ligands Prog Growth Factor Res 4 1992 1 24
82. Roberts A.B. Kondaiah P. Rosa F. Mesoderm induction in Xenopus laevis distinguishes between the various TGF-β isoforms Growth Factors 3 1990 227 237
83. Saperstein L.A. Jirtle R.L. Farouk M. Transforming growth factor-beta 1 and mannose 6-phosphate/insulin-like growth factor II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat Hepatology 19 1994 412 417
84. Schlessinger J. How receptor tyrosine kinases activate Ras. Trends Biochem Sci 18 1993 273 275
85. Schlessinger J. Ullrich A. Growth factor signaling by receptor tyrosine kinases Neuron 9 1992 383 391
86. Schutte M. da Costa L.T. Hahn S.A. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region Proc Natl Acad Sci USA 92 1995 5950 5954
87. Shing Y. Christofori D. Hanahan D. Betacellulin: A mitogen from pancreatic b cell tumors Science 259 1993 1604 1607
88. Siddiqi I. Funatomi H. Kobrin M.S. Increased expression of keratinocyte growth factor in human pancreatic cancer Biochem Biophys Res Commun 215 1995 309 315
89. Smith J.J. Derynck R. Kore M. Production of transforming growth factor a in human pancreatic cancer cells: Evidence for a superagonist autocrine cycle Proc Natl Acad Sci USA 84 1987 7567 7570
90. Soltoff S.P. Carraway K.L. III Prigent S.A. ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor Mol Cell Biol 14 1994 3550 3558
91. Sporn M.B. Roberts A.B. Transforming growth factor-β: Recent progress and new challenges J Cell Biol 119 1992 1017 1021
92. ten Dijke P. Yamashita H. Icjijo H. Characterization of type I receptors for transforming growth factor beta and activin Science 264 1994 101 104
93. Toyoda H. Komurasaki T. Ikeda Y. Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein, expressed in the early stage of development FEBS Lett 377 1995 403 407
94. Venkatasubbarao K. Ahmed M.M. Swiderski C. Microsatellite instability and the status of transforming growth factor-β type II gene in pancreatic adenocarcinoma AACR Proceedings 38 1997 149A
95. Wagner M. Cao T. Lopez M.E. Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum Int J Cancer 68 1996 782 787
96. Wang J. Han W. Zborowska E. Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells J Biol Chem 271 1996 17366 17371
97. Wang X-F Lin H.Y. Ng-Eaton E. Expression cloning and characterization of the TGF-β type III receptor Cell 67 1991 797 805
98. Warshaw A.L. Ferandez-Del Castillo C. Pancreatic carcinoma N Engl J Med 326 1992 455 465
99. Wieser R. Wrana J.L. Massagué J. GS domain mutations that constitutively activate TGF-βRl, the downstream signaling component in the TGF-β receptor complex EMBO J 14 1995 2199 2208
100. Wrana J.L. Attisano L. Carcamo J. TGF-β signals through a heteromeric protein kinase receptor complex Cell 71 1992 1003 1014
101. Wrana J.L. Attisano L. Weiser L. Mechanism of activation of the TGF-β receptor Nature 370 1994 341 347
102. Wu R.Y. Zhang Y. Fen X-H Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4 Mol Cell Biol 17 1997 2521 2528
103. Yamanaka Y. Friess H. Büchler M. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage Cancer Res 53 1993 5289 5296
104. Yamanaka Y. Friess H. Kobrin M.S. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness Anticancer Res 13 1993 565 570
105. Yamanaka Y. Friess H. Kobrin M.S. Overexpression of HER-2 /neu oncogene in human pancreatic carcinoma Hum Pathol 24 1993 1127 1134
106. Yamasaki M. Miyake A. Tagashira S. Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family J Biol Chem 271 1996 15918 15921
107. Yenush L. White M. The IRS-signalling system during insulin and cytokine action Bioessays 19 1997 491 500
108. Yokoyama M. Ebert M. Funatomi H. Amphiregulin is a potent mitogen in human pancreatic cancer cells: Correlation with patient survival International Journal of Oncology 6 1995 625 631
109. Yokoyama M. Funatomi H. Kobrin M.S. Betacellulin, a member of the epidermal growth factor family, is overexpressed in human pancreatic cancer International Journal of Oncology 7 1995 825 829
110. Zuber M.E. Zhou Z. Burrus L.W. Cystein-rich FGF receptor regulates intracellular FGF-1 and FGF-2 levels J Cell Physiol 170 1997 217 227